Imunon Inc (IMNN): Company Short-Term Debt

Official company branding of imunon.com (IMNN)

Imunon, Inc. is developing eco-friendly DNA drug development by minimizing chemical waste. The GURU.Markets service features a line chart of short-term debt load levels, where 0.00 represents the current level of the metric. Financial stability is based on successes in oncology, while operational risks are mitigated by outsourcing plasmid production to certified external partners to eliminate disruptions.

Imunon, Inc. (IMNN) - Company Short-Term Debts from 04/28/2023 to 10/30/2026

Analytical breakdowns and data insights for company Imunon Inc (IMNN)

- stock price and consensus target price:
Stock Price Celsion Corporation|IMNN - Analyst Median Target
- stock exchange capitalization data:
Market Value Imunon, Inc.|IMNN - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Accounting Value per Share Imunon|IMNN - Book Capitalization|Market Value to Book Value Ratio imunon.com|IMNN - Total Business Assets
- debt and liquidity data:
Debt to Equity Imunon, Inc.|IMNN - Long-Term Liabilities to Capital|Short-Term Debt to Equity Celsion Corporation|IMNN - Company Aggregate Debt|Debt to Book Value Imunon, Inc.|IMNN - Company Long-Term Loans and Borrowings|Company Short-Term Debts Imunon|Quick Liquidity imunon.com
- earnings and valuation multiples indicators:
IMNN - Company Profit
Fundamental valuation:imunon.com - IMNN
Mass-produced product of Celsion Corporation

This indicator measures the repayment speed of current credit lines and promissory notes, allowing a risk manager to differentiate planned payments from forced asset liquidation when discounting business value. Analyzing the volume of short-term liabilities is critically important for Imunon, Inc. (IMNN), as the absence of M&A deals leaves the company dependent on future licensing agreements to cover expenses for late-stage clinical trials.

Competing companies

Tempus AI, Inc - Company Short-Term Debts|Short-Term Debt Volume Qiagen NV QGEN|Ionis Pharma (IONS) - Company Short-Term Debt|Company Current Liabilities Repligen Inc.|Company Current Liabilities RNA|Company Short-Term Debts crisprtx.com|Company Short-Term Debt GeneDx (WGS)|Ultragenyx Pharmaceutical Inc. - Company Short-Term Indebtedness|Company Short-Term Debt Beam Therapeutics Corp BEAM|Sarepta Corp (SRPT) - Short-Term Debt|TWST - Company Short-Term Debt|TXG (10xgenomics.com) - Company Short-Term Indebtedness|NTLA (Intellia Therapeutics, Inc.) - Company Current Liabilities|Stoke Therapeutics Inc - Company Short-Term Loans and Borrowings|BLFS (BioLife Corp) - Company Short-Term Debts|Wave Pharma (WVE) - Short-Term Debt Volume|Company Short-Term Debt Maze Therapeutics Inc (MAZE)|sionnatx.com - Company Short-Term Indebtedness|Company Short-Term Debts PRME (Prime Medicine)|TSHA - Company Current Liabilities|QURE: Company Current Liabilities|Short-Term Debt Volume MeiraGTx Corp MGTX|RGNX: Company Short-Term Debts|SLDB - Short-Term Debt Volume|Company Short-Term Debt Ocugen|Company Current Liabilities Pacific Biosciences of California, Inc. (PACB)|Company Short-Term Debt Benitec (BNTC)|Design Corp - Company Short-Term Indebtedness|Company Short-Term Debt Rocket Pharmaceuticals RCKT|FDMT: Company Short-Term Indebtedness|Lexeo - Company Short-Term Debts|KRRO (Korro Bio, Inc.) - Company Short-Term Indebtedness|Editas (EDIT) - Company Short-Term Debt|Company Short-Term Indebtedness SLN|PRQR (ProQR) - Company Short-Term Debts|Company Short-Term Debts Codexis Bio|Company Short-Term Debts SGMO|Short-Term Debt Volume nautilus.bio|Company Short-Term Debt Metagenomi, Inc MGX|DTIL - Company Current Liabilities|GBIO: Company Current Liabilities|BOLD - Company Short-Term Debts|exicuretx.com (XCUR) - Company Short-Term Debt|Company Short-Term Indebtedness PHIO|Company Short-Term Debt Mustang Bio Inc|Short-Term Debt TransCode RNAZ|Company Short-Term Debt Bionano Genomics, Inc. (BNGO)|adnas.com - Company Short-Term Indebtedness|bluebird bio - Company Current Liabilities|Company Short-Term Loans and Borrowings IPA|Omega - Company Short-Term Debts|Short-Term Debt Volume Singular Genomics Corp OMIC|Regulus Therapeutics (RGLS) - Company Short-Term Debt|Company Short-Term Indebtedness SYRS|TBIO (Telesis Bio) - Company Short-Term Debts|Company Current Liabilities TRACON Pharmaceuticals Inc. (TCON)|Company Current Liabilities UBX (Unity Bio)